239 related articles for article (PubMed ID: 1383635)
1. Pituitary adenylate cyclase activating polypeptide is a potent vasodilator in humans.
Warren JB; Cockcroft JR; Larkin SW; Kajekar R; Macrae A; Ghatei MA; Bloom SR
J Cardiovasc Pharmacol; 1992 Jul; 20(1):83-7. PubMed ID: 1383635
[TBL] [Abstract][Full Text] [Related]
2. Calcitonin gene-related peptide-induced vasodilation in the human forearm is antagonized by CGRP8-37: evaluation of a human in vivo pharmacodynamic model.
Vanmolkot FH; Van der Schueren BJ; de Hoon JN
Clin Pharmacol Ther; 2006 Mar; 79(3):263-73. PubMed ID: 16513450
[TBL] [Abstract][Full Text] [Related]
3. Pituitary adenylate cyclase activating polypeptide is a potent vasodilator and oedema potentiator in rabbit skin in vivo.
Warren JB; Larkin SW; Coughlan M; Kajekar R; Williams TJ
Br J Pharmacol; 1992 Jun; 106(2):331-4. PubMed ID: 1393266
[TBL] [Abstract][Full Text] [Related]
4. Effect of pituitary adenylate cyclase-activating polypeptide 38 (PACAP38) on tissue oxygen content--treatment in central nervous system of mice.
Ohtaki H; Dohi K; Yofu S; Nakamachi T; Kudo Y; Endo S; Aruga T; Goto N; Watanabe J; Kikuyama S; Shioda S
Regul Pept; 2004 Dec; 123(1-3):61-7. PubMed ID: 15518894
[TBL] [Abstract][Full Text] [Related]
5. Ventilatory and cardiovascular actions of centrally and peripherally administered trout pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) in the unanaesthetized trout.
Le Mével JC; Lancien F; Mimassi N; Conlon JM
J Exp Biol; 2009 Dec; 212(Pt 23):3919-27. PubMed ID: 19915135
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) on food intake in the goldfish, Carassius auratus.
Matsuda K; Maruyama K; Nakamachi T; Miura T; Uchiyama M; Shioda S
Peptides; 2005 Sep; 26(9):1611-6. PubMed ID: 16112400
[TBL] [Abstract][Full Text] [Related]
7. Pituitary adenylate cyclase-activating polypeptide (PACAP): effects on blood flow in the testis and caput epididymidis of the rat.
Lissbrant E; Collin O; Bergh A
J Androl; 1999; 20(3):366-74. PubMed ID: 10386816
[TBL] [Abstract][Full Text] [Related]
8. The vasorelaxant effect of adrenomedullin, proadrenomedullin N-terminal 20 peptide and amylin in human skin.
Hasbak P; Eskesen K; Lind H; Holst J; Edvinsson L
Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):162-7. PubMed ID: 16918718
[TBL] [Abstract][Full Text] [Related]
9. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
J Immunol; 1999 Feb; 162(3):1707-16. PubMed ID: 9973433
[TBL] [Abstract][Full Text] [Related]
10. [Neuroprotective effects of novel derivatives of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide in two brain ischemic models on mice].
Takeda N; Murozono M; Watanabe S; Isshiki A; Watanabe Y
Masui; 2005 Mar; 54(3):240-8. PubMed ID: 15794099
[TBL] [Abstract][Full Text] [Related]
11. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
Zawilska JB; Niewiadomski P; Nowak JZ
Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
[TBL] [Abstract][Full Text] [Related]
12. Anorexigenic effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide in the chick brain are mediated by corticotrophin-releasing factor.
Tachibana T; Saito ES; Takahashi H; Saito S; Tomonaga S; Boswell T; Furuse M
Regul Pept; 2004 Aug; 120(1-3):99-105. PubMed ID: 15177926
[TBL] [Abstract][Full Text] [Related]
13. Prolonged microvascular vasodilation induced by leukotriene B4 in human skin is cyclooxygenase independent.
Larkin SW; Fraser L; Showell HJ; Williams TJ; Warren JB
J Pharmacol Exp Ther; 1995 Jan; 272(1):392-8. PubMed ID: 7815355
[TBL] [Abstract][Full Text] [Related]
14. Gastrin-releasing peptide is a potent vasodilator in humans.
Clive S; Jodrell D; Webb D
Clin Pharmacol Ther; 2001 Apr; 69(4):252-9. PubMed ID: 11309554
[TBL] [Abstract][Full Text] [Related]
15. Reproducibility of forearm vasodilator response to intra-arterial infusion of calcitonin gene-related peptide assessed by venous occlusion plethysmography.
Vanmolkot FH; de Hoon JN
Br J Clin Pharmacol; 2005 Apr; 59(4):387-97. PubMed ID: 15801933
[TBL] [Abstract][Full Text] [Related]
16. PACAP-38 infusion causes sustained vasodilation of the middle meningeal artery in the rat: possible involvement of mast cells.
Bhatt DK; Gupta S; Olesen J; Jansen-Olesen I
Cephalalgia; 2014 Oct; 34(11):877-86. PubMed ID: 24563332
[TBL] [Abstract][Full Text] [Related]
17. Pituitary adenylate cyclase activating polypeptide (PACAP) redistributes the blood within the pancreas of anesthetized rats.
Carlsson PO; Ostenson CG; Efendic S; Langel U; Jansson L
Regul Pept; 1996 Jul; 63(2-3):123-8. PubMed ID: 8837220
[TBL] [Abstract][Full Text] [Related]
18. Pituitary adenylate cyclase activating polypeptide: a neuropeptide with potent inotropic and coronary vasodilatory effects in neonatal pig hearts.
Ross-Ascuitto NT; Ascuitto RJ; Ramage D; Kydon DW; Coy DH; Kadowitz PJ
Pediatr Res; 1993 Sep; 34(3):323-8. PubMed ID: 7510869
[TBL] [Abstract][Full Text] [Related]
19. Vasodilator effect of pituitary adenylate cyclase activating polypeptide (PACAP) on femoral blood flow in dogs.
Naruse S; Suzuki T; Ozaki T; Nokihara K
Peptides; 1993; 14(3):505-10. PubMed ID: 8101368
[TBL] [Abstract][Full Text] [Related]
20. Regional haemodynamic responses to pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide in conscious rats.
Gardiner SM; Rakhit T; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1994 Feb; 111(2):589-97. PubMed ID: 7911721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
